Armon Sharei, PhD Immunology, Harvard University

SQZ Biotechnology

Poster(s):

• Tu109 - SQZ® TAC Cell Therapy Platform Induces Antigen Specific T-regs and Prevents Onset of Type 1 Diabetes in Adoptive Transfer Models
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT